Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 434

1.

Nanoparticle and targeted systems for cancer therapy.

Brannon-Peppas L, Blanchette JO.

Adv Drug Deliv Rev. 2004 Sep 22;56(11):1649-59. Review. Erratum in: Adv Drug Deliv Rev. 2009 Apr 28;61(4):364.

PMID:
15350294
2.

Molecular targeting of drug delivery systems to cancer.

Minko T, Dharap SS, Pakunlu RI, Wang Y.

Curr Drug Targets. 2004 May;5(4):389-406. Review.

PMID:
15134222
3.

Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery.

van Vlerken LE, Vyas TK, Amiji MM.

Pharm Res. 2007 Aug;24(8):1405-14. Review.

PMID:
17393074
4.

Liposomes as targeted drug delivery systems in the treatment of breast cancer.

Sharma G, Anabousi S, Ehrhardt C, Ravi Kumar MN.

J Drug Target. 2006 Jun;14(5):301-10. Review.

PMID:
16882550
5.

Nanotechnology-based drug delivery for cancer.

Jain KK.

Technol Cancer Res Treat. 2005 Aug;4(4):407-16. Review.

PMID:
16029059
6.

Nanoparticles for tumor targeted therapies and their pharmacokinetics.

Wang J, Sui M, Fan W.

Curr Drug Metab. 2010 Feb;11(2):129-41. Review.

PMID:
20359289
7.

Active targeting schemes for nanoparticle systems in cancer therapeutics.

Byrne JD, Betancourt T, Brannon-Peppas L.

Adv Drug Deliv Rev. 2008 Dec 14;60(15):1615-26. doi: 10.1016/j.addr.2008.08.005. Review.

PMID:
18840489
8.

Targeted nucleic acid delivery into tumors: new avenues for cancer therapy.

Wagner E, Kircheis R, Walker GF.

Biomed Pharmacother. 2004 Apr;58(3):152-61. Review.

PMID:
15082337
9.

Polymeric nanoparticles for cancer therapy.

Parveen S, Sahoo SK.

J Drug Target. 2008 Feb;16(2):108-23. doi: 10.1080/10611860701794353 . Review.

PMID:
18274932
10.

Ligand-targeted liposomes for cancer treatment.

Sapra P, Tyagi P, Allen TM.

Curr Drug Deliv. 2005 Oct;2(4):369-81. Review.

PMID:
16305440
11.

Encapsulation of nucleic acids and opportunities for cancer treatment.

Brannon-Peppas L, Ghosn B, Roy K, Cornetta K.

Pharm Res. 2007 Apr;24(4):618-27. Review.

PMID:
17372693
12.

Development of ligand-targeted liposomes for cancer therapy.

Noble CO, Kirpotin DB, Hayes ME, Mamot C, Hong K, Park JW, Benz CC, Marks JD, Drummond DC.

Expert Opin Ther Targets. 2004 Aug;8(4):335-53. Review.

PMID:
15268628
13.

Nanoparticle technologies for cancer therapy.

Alexis F, Pridgen EM, Langer R, Farokhzad OC.

Handb Exp Pharmacol. 2010;(197):55-86. doi: 10.1007/978-3-642-00477-3_2. Review.

PMID:
20217526
14.

Integrin targeted drug and gene delivery.

Wang Z, Chui WK, Ho PC.

Expert Opin Drug Deliv. 2010 Feb;7(2):159-71. doi: 10.1517/17425240903468696. Review.

PMID:
20095940
15.

Specific targets in tumor tissue for the delivery of therapeutic genes.

G√ľnther M, Wagner E, Ogris M.

Curr Med Chem Anticancer Agents. 2005 Mar;5(2):157-71. Review.

PMID:
15777223
16.

Exploiting the enhanced permeability and retention effect for tumor targeting.

Iyer AK, Khaled G, Fang J, Maeda H.

Drug Discov Today. 2006 Sep;11(17-18):812-8. Review.

PMID:
16935749
17.

[Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].

Chen JN, Shen Q, Li SS.

Yao Xue Xue Bao. 2009 Apr;44(4):333-7. Review. Chinese.

PMID:
19545047
18.

Use of nanoparticles for drug delivery in glioblastoma multiforme.

Jain KK.

Expert Rev Neurother. 2007 Apr;7(4):363-72. Review.

PMID:
17425491
19.

Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours.

Cegnar M, Kristl J, Kos J.

Expert Opin Biol Ther. 2005 Dec;5(12):1557-69. Review.

PMID:
16318420
20.

Targeting strategies in cancer gene therapy.

Wang JH, Liu XY.

Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Apr;35(4):311-6. Review.

Items per page

Supplemental Content

Support Center